| |
| |
|
| Insider
Information: |
Tarriff Scott L |
| Relationship: |
President & CEO, Direc... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
96,061 |
|
|
Indirect Shares
|
1,500 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,561 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
President & CEO, Direc... |
2006-01-09 |
96,061 |
2006-01-09 |
1,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRX |
Par Pharmaceutical Compan... |
officerTitle |
• • – |
2006-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
26,399 |
47,461 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2005-09-07 |
4 |
B |
$24.99 |
$124,950 |
D/D |
5,000 |
48,600 |
2.81 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2005-08-08 |
4 |
B |
$23.96 |
$239,997 |
D/D |
10,000 |
43,600 |
2.81 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2005-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,062 |
21,062 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2004-12-15 |
4 |
B |
$39.59 |
$198,214 |
D/D |
5,000 |
118,600 |
2.81 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2004-09-21 |
4 |
B |
$39.70 |
$198,500 |
D/D |
5,000 |
113,600 |
2.81 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2004-06-03 |
4 |
B |
$42.42 |
$365,081 |
D/D |
8,600 |
108,600 |
2.81 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & Chief Exe Officer |
• • – |
2003-12-02 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
1,500 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & Chief Exe Officer |
• • – |
2003-12-02 |
4 |
OE |
$25.85 |
$2,361,750 |
D/D |
85,000 |
100,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2003-11-17 |
4 |
S |
$71.76 |
$5,059,355 |
D/D |
(70,500) |
15,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
President & CEO |
• • – |
2003-11-17 |
4 |
OE |
$30.55 |
$2,153,775 |
D/D |
70,500 |
85,500 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres&CEO of Par Pharmaceutical |
• • – |
2003-06-30 |
4 |
S |
$48.33 |
$1,933,200 |
D/D |
(40,000) |
15,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres&CEO of Par Pharmaceutical |
• • – |
2003-06-30 |
4 |
OE |
$7.63 |
$1,038,600 |
D/D |
40,000 |
55,000 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
Pres&CEO of Par Pharmaceutical |
• • – |
1998-08-08 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
1,500 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
